|                                 |
|---------------------------------|
|                                 |  |
| Media Contact                   | October 26, 2017 |
| Casey Lassiter, 205 447-6410    | For Immediate Release |
| casey.lassiter@healthsouth.com  |   |
|                            |   |
| Investor Relations Contact      |   |
| Crissy Carlisle, 205 970-5860   |   |
| crissy.carlisle@healthsouth.com |   |

|                                                                         |
|-------------------------------------------------------------------------|
|                                                                         |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
|                                                                    |   |   |   |   | Growth |
|                                                                    | Q3 2017 |   | Q3 2016 |   | Dollars |   | Percent |
|                                                                    | (In Millions, Except per Share Data) |
| Net operating revenues                                                  | $ | 995.6 |  |   | $ | 926.8 |  |   | $ | 68.8 |  |   | 7.4 |  % |
| Income from continuing operations attributable to HealthSouth per share | 0.67 |  |   | 0.64 |  |   | 0.03 |  |   | 4.7 |  % |
| Adjusted earnings per share                                             | 0.66 |  |   | 0.65 |  |   | 0.01 |  |   | 1.5 |  % |
| Cash flows provided by operating activities                             | 173.8 |  |   | 177.6 |  |   | (3.8 | ) |   | (2.1 | )% |
| Adjusted EBITDA                                                         | 204.6 |  |   | 198.4 |  |   | 6.2 |  |   | 3.1 |  % |
| Adjusted free cash flow                                                 | 122.1 |  |   | 139.8 |  |   | (17.7 | ) |   | (12.7 | )% |
|                                                                    | Nine Months Ended September 30, |   |   |   |   |
|                                                                    | 2017 |   | 2016 |   |   |   |   |
| Cash flows provided by operating activities                             | $ | 505.8 |  |   | $ | 499.4 |  |   | $ | 6.4 |  |   | 1.3 |  % |
| Adjusted free cash flow                                                 | 376.1 |  |   | 394.5 |  |   | (18.4 | ) |   | (4.7 | )% |

|        |
|--------|
|        |  |  |
|   |   | 1 |

----

|                                   |
|-----------------------------------|
|                                   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
|                              |   |   |   |   | Growth |
|                              | Q3 2017 |   | Q3 2016 |   | Dollars |   | Percent |
| Net operating revenues:           | (In Millions) |
| Inpatient                         | $ | 768.6 |  |   | $ | 724.1 |  |   | $ | 44.5 |  |   | 6.1 |  % |
| Outpatient and other              | 26.2 |  |   | 27.6 |  |   | (1.4 | ) |   | (5.1 | )% |
| Total segment revenue             | $ | 794.8 |  |   | $ | 751.7 |  |   | $ | 43.1 |  |   | 5.7 |  % |
|                              |   |   |   |   |   |   |   |
|                              | (Actual Amounts) |
| Discharges                        | 42,948 |  |   | 41,368 |  |   | 1,580 |  |   | 3.8 |  % |
| Same-store discharge growth       |   |   |   |   |   |   | 1.4 |  % |
| Net patient revenue per discharge | $ | 17,896 |  |   | $ | 17,504 |  |   | $ | 392 |  |   | 2.2 |  % |
|                              |   |   |   |   |   |   |   |
|                              | (In Millions) |
| Adjusted EBITDA                   | $ | 200.3 |  |   | $ | 198.6 |  |   | $ | 1.7 |  |   | 0.9 |  % |

|         |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
|---------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| • | Revenue - Revenue growth resulted from volume growth and an increase in net patient revenue per discharge. Discharge growth from new stores resulted from the Company's joint ventures in Bryan, Texas (August 2016), Broken Arrow, Oklahoma (August 2016), Gulfport, Mississippi (April 2017), Westerville, Ohio (April 2017), and Jackson, Tennessee (July 2017), as well as a wholly owned hospital in Modesto, California (October 2016). Same-store discharge growth of 1.4% in the third quarter of 2017 was negatively impacted 200 to 250 discharges, or 50 to 60 basis points, due to Hurricanes Harvey, Irma, and Maria. Growth in net patient revenue per discharge primarily resulted from patient mix. Net patient revenue per discharge in the third quarter of 2016 included the benefit of a retroactive indirect medical education (“IME”) adjustment of approximately $4 million at the former Reliant hospital in Woburn, Massachusetts. |

|         |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  |
|---------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| • | Adjusted EBITDA - The increase in Adjusted EBITDA for the inpatient rehabilitation segment primarily resulted from revenue growth. Expense ratios in the third quarter of 2017 compared to the third quarter of 2016 were negatively impacted by the aforementioned IME adjustment and $2.5 million in hurricane-related expenses in the third quarter of 2017. Salaries and benefits as a percent of net operating revenues were further impacted by salary and benefit cost increases, staffing increases at the former Reliant hospitals, and the ramping up of new stores. Bad debt expense as a percent of net operating revenues decreased from 1.8% in the third quarter of 2016 to 1.4% in the third quarter of 2017 primarily due to a reduction in new pre-payment claims denials. |

|        |
|--------|
|        |  |  |
|   |   | 2 |

----

|                              |
|------------------------------|
|                              |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
|                         |   |   |   |   | Growth |
|                         | Q3 2017 |   | Q3 2016 |   | Dollars |   | Percent |
| Net operating revenues:      | (In Millions) |
| Home health                  | $ | 181.2 |  |   | $ | 162.0 |  |   | $ | 19.2 |  |   | 11.9 |  % |
| Hospice and other            | 19.6 |  |   | 13.1 |  |   | 6.5 |  |   | 49.6 |  % |
| Total segment revenue        | $ | 200.8 |  |   | $ | 175.1 |  |   | $ | 25.7 |  |   | 14.7 |  % |
|                         |   |   |   |   |   |   |   |
|                         | (Actual Amounts) |
| Admissions                   | 31,471 |  |   | 27,239 |  |   | 4,232 |  |   | 15.5 |  % |
| Same-store admissions growth |   |   |   |   |   |   | 8.8 |  % |
| Episodes                     | 53,757 |  |   | 46,866 |  |   | 6,891 |  |   | 14.7 |  % |
| Same-store episode growth    |   |   |   |   |   |   | 9.5 |  % |
| Revenue per episode          | $ | 3,022 |  |   | $ | 3,032 |  |   | $ | (10 | ) |   | (0.3 | )% |
|                         |   |   |   |   |   |   |   |
|                         | (In Millions) |
| Adjusted EBITDA              | $ | 34.8 |  |   | $ | 25.8 |  |   | $ | 9.0 |  |   | 34.9 |  % |

|         |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
|---------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| • | Revenue - Revenue growth resulted from strong same-store and new-store volume growth. Same-store admission growth of 8.8% in the third quarter of 2017 was negatively impacted 325 to 375 admissions, or 120 to 140 basis points, due to Hurricanes Harvey and Irma. The decrease in revenue per episode resulted from Medicare reimbursement rate cuts partially offset by changes in patient mix and reconciliation payments attributed to various alternative payment models (e.g., BPCI; ACOs). |

|         |                                                                                                                                                                                                                                                                                                                                                                                                                                   |
|---------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| • | Adjusted EBITDA - Growth in Adjusted EBITDA primarily resulted from revenue growth and staffing productivity gains. Adjusted EBITDA for the home health and hospice segment for the third quarter of 2017 included a $0.9 million benefit from the true-up to the purchase price of a 2016 acquisition. Adjusted EBITDA for the third quarter of 2017 also included approximately $0.3 million in hurricane-related expenses. |

|                                                                         |
|-------------------------------------------------------------------------|
|                                                                         |  |  |  |  |  |  |  |  |  |  |  |
|                                                                    | Q3 2017 |   | % of Consolidated Revenue |   | Q3 2016 |   | % of Consolidated Revenue |
|                                                                    | (In Millions) |
| General and administrative expenses, excluding stock-based compensation | $ | 30.5 |  |   | 3.1% |   | $ | 26.0 |  |   | 2.8% |

|         |                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
|---------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| • | General and administrative expenses increased as a percent of consolidated revenue primarily due to expenses associated with the Company's rebranding and name change and TeamWorks clinical collaboration initiative. During the third quarter of 2017, the Company invested $1.5 million in its rebranding and name change and $2.3 million in its TeamWorks clinical collaboration initiative, all of which was included in general and administrative expenses. |

|        |
|--------|
|        |  |  |
|   |   | 3 |

----

|                                                                                    |
|------------------------------------------------------------------------------------|
|                                                                                    |  |  |  |
|                                                                               | Full-Year 2017 Guidance Ranges |
|                                                                               | Previous Guidance |   | Updated Guidance |
|                                                                               | (In Millions, Except Per Share Data) |
| Net operating revenues                                                             | $3,875 to $3,950 |   | $3,900 to $3,950 |
| Adjusted EBITDA                                                                    | $805 to $820 |   | $810 to $820 |
| Adjusted earnings per share from continuing operations attributable to HealthSouth | $2.64 to $2.73 |   | $2.67 to $2.73 |

|         |                                                                                      |
|---------|--------------------------------------------------------------------------------------|
| • | Provision for doubtful accounts - estimate of 1.6% to 1.8% of net operating revenues |

|         |                                                                                                         |
|---------|---------------------------------------------------------------------------------------------------------|
| • | Interest expense and amortization of debt discounts and fees - estimate of $155 million to $160 million |

|         |                                                                |
|---------|----------------------------------------------------------------|
| • | Amortization of debt-related items - approximately $10 million |

|        |
|--------|
|        |  |  |
|   |   | 4 |

----

|                                                              |
|--------------------------------------------------------------|
|                                                              |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
|                                                         | Three Months Ended September 30, |   | Nine Months Ended September 30, |
|                                                         | 2017 |   | 2016 |   | 2017 |   | 2016 |
|                                                         | (In Millions) |
| Net operating revenues                                       | $ | 995.6 |  |   | $ | 926.8 |  |   | $ | 2,951.7 |  |   | $ | 2,757.3 |  |
| Less: Provision for doubtful accounts                        | (12.6 | ) |   | (14.8 | ) |   | (42.7 | ) |   | (46.7 | ) |
| Net operating revenues less provision for doubtful accounts  | 983.0 |  |   | 912.0 |  |   | 2,909.0 |  |   | 2,710.6 |  |
| Operating expenses:                                          |   |  |   |   |  |   |   |   |   |
| Salaries and benefits                                        | 542.1 |  |   | 497.4 |  |   | 1,600.0 |  |   | 1,469.6 |  |
| Other operating expenses                                     | 137.6 |  |   | 126.3 |  |   | 397.2 |  |   | 367.0 |  |
| Occupancy costs                                              | 18.6 |  |   | 17.6 |  |   | 54.8 |  |   | 53.5 |  |
| Supplies                                                     | 36.5 |  |   | 34.8 |  |   | 110.6 |  |   | 104.2 |  |
| General and administrative expenses                          | 39.7 |  |   | 30.3 |  |   | 128.6 |  |   | 96.6 |  |
| Depreciation and amortization                                | 46.2 |  |   | 43.5 |  |   | 137.2 |  |   | 128.8 |  |
| Professional fees—accounting, tax, and legal           | — |  |   | — |  |   | — |  |   | 1.9 |  |
| Total operating expenses                                     | 820.7 |  |   | 749.9 |  |   | 2,428.4 |  |   | 2,221.6 |  |
| Loss on early extinguishment of debt                         | 0.3 |  |   | 2.6 |  |   | 10.7 |  |   | 7.4 |  |
| Interest expense and amortization of debt discounts and fees | 36.8 |  |   | 42.5 |  |   | 118.5 |  |   | 130.5 |  |
| Other income                                                 | (1.0 | ) |   | (0.8 | ) |   | (2.9 | ) |   | (2.1 | ) |
| Equity in net income of nonconsolidated affiliates           | (2.1 | ) |   | (2.5 | ) |   | (6.2 | ) |   | (7.3 | ) |
| Income from continuing operations before income tax expense  | 128.3 |  |   | 120.3 |  |   | 360.5 |  |   | 360.5 |  |
| Provision for income tax expense                             | 43.1 |  |   | 42.1 |  |   | 111.4 |  |   | 124.2 |  |
| Income from continuing operations                            | 85.2 |  |   | 78.2 |  |   | 249.1 |  |   | 236.3 |  |
| Loss from discontinued operations, net of tax                | (0.1 | ) |   | (0.1 | ) |   | (0.2 | ) |   | (0.3 | ) |
| Net income                                                   | 85.1 |  |   | 78.1 |  |   | 248.9 |  |   | 236.0 |  |
| Less: Net income attributable to noncontrolling interests    | (19.2 | ) |   | (16.4 | ) |   | (53.2 | ) |   | (53.7 | ) |
| Net income attributable to HealthSouth                       | $ | 65.9 |  |   | $ | 61.7 |  |   | $ | 195.7 |  |   | $ | 182.3 |  |

|        |
|--------|
|        |  |  |
|   | (Continued) | 5 |

----

|                                                                             |
|-----------------------------------------------------------------------------|
|                                                                             |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
|                                                                        | Three Months Ended September 30, |   | Nine Months Ended September 30, |
|                                                                        | 2017 |   | 2016 |   | 2017 |   | 2016 |
|                                                                        | (In Millions, Except Per Share Data) |
| Weighted average common shares outstanding:                                 |   |  |   |   |  |   |   |   |   |
| Basic                                                                       | 97.8 |  |   | 89.1 |  |   | 92.3 |  |   | 89.3 |  |
| Diluted                                                                     | 99.0 |  |   | 99.4 |  |   | 99.1 |  |   | 99.5 |  |
|                                                                        |   |   |   |   |   |   |   |
| Earnings per common share:                                                  |   |   |   |   |   |   |   |
| Basic earnings per share attributable to HealthSouth common shareholders:   |   |   |   |  |   |   |   |   |
| Continuing operations                                                       | $ | 0.67 |  |   | $ | 0.69 |  |   | $ | 2.11 |  |   | $ | 2.03 |  |
| Discontinued operations                                                     | — |  |   | — |  |   | — |  |   | — |  |
| Net income                                                                  | $ | 0.67 |  |   | $ | 0.69 |  |   | $ | 2.11 |  |   | $ | 2.03 |  |
| Diluted earnings per share attributable to HealthSouth common shareholders: |   |   |   |   |   |   |   |
| Continuing operations                                                       | $ | 0.67 |  |   | $ | 0.64 |  |   | $ | 2.08 |  |   | $ | 1.90 |  |
| Discontinued operations                                                     | — |  |   | — |  |   | — |  |   | — |  |
| Net income                                                                  | $ | 0.67 |  |   | $ | 0.64 |  |   | $ | 2.08 |  |   | $ | 1.90 |  |
|                                                                        |   |   |   |   |   |   |   |
| Cash dividends per common share                                             | $ | 0.25 |  |   | $ | 0.24 |  |   | $ | 0.73 |  |   | $ | 0.70 |  |
|                                                                        |   |   |   |   |   |   |   |
| Amounts attributable to HealthSouth common shareholders:                    |   |   |   |  |   |   |   |   |
| Income from continuing operations                                           | $ | 66.0 |  |   | $ | 61.8 |  |   | $ | 195.9 |  |   | $ | 182.6 |  |
| Loss from discontinued operations, net of tax                               | (0.1 | ) |   | (0.1 | ) |   | (0.2 | ) |   | (0.3 | ) |
| Net income attributable to HealthSouth                                      | $ | 65.9 |  |   | $ | 61.7 |  |   | $ | 195.7 |  |   | $ | 182.3 |  |

|        |
|--------|
|        |  |  |
|   |   | 6 |

----

|                                                                                             |
|---------------------------------------------------------------------------------------------|
|                                                                                             |  |  |  |  |  |  |  |
|                                                                                        | September 30, 2017 |   | December 31, 2016 |
|                                                                                        | (In Millions) |
| Assets                                                                                      |   |   |   |
| Current assets:                                                                             |   |   |   |
| Cash and cash equivalents                                                                   | $ | 67.6 |  |   | $ | 40.5 |  |
| Accounts receivable, net of allowance for doubtful accounts of $58.5 in 2017; $53.9 in 2016 | 441.6 |  |   | 443.8 |  |
| Other current assets                                                                        | 178.2 |  |   | 170.2 |  |
| Total current assets                                                                        | 687.4 |  |   | 654.5 |  |
| Property and equipment, net                                                                 | 1,482.3 |  |   | 1,391.8 |  |
| Goodwill                                                                                    | 1,971.7 |  |   | 1,927.2 |  |
| Intangible assets, net                                                                      | 405.1 |  |   | 411.3 |  |
| Deferred income tax assets                                                                  | 91.6 |  |   | 75.8 |  |
| Other long-term assets                                                                      | 245.3 |  |   | 221.3 |  |
| Total assets                                                                                | $ | 4,883.4 |  |   | $ | 4,681.9 |  |
| Liabilities and Shareholders’ Equity                                                  |   |   |   |
| Current liabilities:                                                                        |   |   |   |
| Current portion of long-term debt                                                           | $ | 31.1 |  |   | $ | 37.1 |  |
| Accounts payable                                                                            | 81.8 |  |   | 68.3 |  |
| Accrued expenses and other current liabilities                                              | 398.3 |  |   | 370.2 |  |
| Total current liabilities                                                                   | 511.2 |  |   | 475.6 |  |
| Long-term debt, net of current portion                                                      | 2,591.3 |  |   | 2,979.3 |  |
| Other long-term liabilities                                                                 | 186.4 |  |   | 160.0 |  |
|                                                                                        | 3,288.9 |  |   | 3,614.9 |  |
| Commitments and contingencies                                                               |   |   |   |
| Redeemable noncontrolling interests                                                         | 221.3 |  |   | 138.3 |  |
| Shareholders’ equity:                                                                 |   |  |   |   |  |
| HealthSouth shareholders’ equity                                                      | 1,136.4 |  |   | 735.9 |  |
| Noncontrolling interests                                                                    | 236.8 |  |   | 192.8 |  |
| Total shareholders’ equity                                                            | 1,373.2 |  |   | 928.7 |  |
| Total liabilities and shareholders’ equity                                            | $ | 4,883.4 |  |   | $ | 4,681.9 |  |

|        |
|--------|
|        |  |  |
|   |   | 7 |

----

|                                                                                         |
|-----------------------------------------------------------------------------------------|
|                                                                                         |  |  |  |  |  |  |  |
|                                                                                    | Nine Months Ended September 30, |
|                                                                                    | 2017 |   | 2016 |
|                                                                                    | (In Millions) |
| Cash flows from operating activities:                                                   |   |   |   |
| Net income                                                                              | $ | 248.9 |  |   | $ | 236.0 |  |
| Loss from discontinued operations, net of tax                                           | 0.2 |  |   | 0.3 |  |
| Adjustments to reconcile net income to net cash provided by operating activities— |   |  |   |   |  |
| Provision for doubtful accounts                                                         | 42.7 |  |   | 46.7 |  |
| Depreciation and amortization                                                           | 137.2 |  |   | 128.8 |  |
| Loss on early extinguishment of debt                                                    | 10.7 |  |   | 7.4 |  |
| Equity in net income of nonconsolidated affiliates                                      | (6.2 | ) |   | (7.3 | ) |
| Distributions from nonconsolidated affiliates                                           | 6.6 |  |   | 5.9 |  |
| Stock-based compensation                                                                | 37.9 |  |   | 17.4 |  |
| Deferred tax expense                                                                    | 51.3 |  |   | 110.6 |  |
| Other, net                                                                              | 9.8 |  |   | 11.7 |  |
| Change in assets and liabilities, net of acquisitions—                            |   |   |   |  |
| Accounts receivable                                                                     | (54.2 | ) |   | (75.7 | ) |
| Other assets                                                                            | (7.4 | ) |   | (4.4 | ) |
| Accounts payable                                                                        | 6.1 |  |   | 1.9 |  |
| Accrued payroll                                                                         | 3.1 |  |   | 8.7 |  |
| Accrued interest payable                                                                | 7.3 |  |   | 6.0 |  |
| Other liabilities                                                                       | 12.5 |  |   | 11.8 |  |
| Premium paid on redemption of bonds                                                     | — |  |   | (5.8 | ) |
| Net cash used in operating activities of discontinued operations                        | (0.7 | ) |   | (0.6 | ) |
| Total adjustments                                                                       | 256.7 |  |   | 263.1 |  |
| Net cash provided by operating activities                                               | 505.8 |  |   | 499.4 |  |
|                                                                                    |   |   |   |

|        |
|--------|
|        |  |  |
|   | (Continued) | 8 |

----

|                                                                           |
|---------------------------------------------------------------------------|
|                                                                           |  |  |  |  |  |  |  |
|                                                                      | Nine Months Ended September 30, |
|                                                                      | 2017 |   | 2016 |
|                                                                      | (In Millions) |
| Cash flows from investing activities:                                     |   |   |   |
| Purchases of property and equipment                                       | (155.7 | ) |   | (113.9 | ) |
| Additions to capitalized software costs                                   | (14.6 | ) |   | (17.5 | ) |
| Acquisitions of businesses, net of cash acquired                          | (36.6 | ) |   | (19.6 | ) |
| Net change in restricted cash                                             | (9.9 | ) |   | (7.1 | ) |
| Other, net                                                                | 7.6 |  |   | 1.8 |  |
| Net cash used in investing activities                                     | (209.2 | ) |   | (156.3 | ) |
| Cash flows from financing activities:                                     |   |   |   |
| Principal payments on debt, including pre-payments                        | (125.4 | ) |   | (195.2 | ) |
| Borrowings on revolving credit facility                                   | 241.3 |  |   | 260.0 |  |
| Payments on revolving credit facility                                     | (255.3 | ) |   | (240.0 | ) |
| Repurchases of common stock, including fees and expenses                  | (38.1 | ) |   | (24.1 | ) |
| Dividends paid on common stock                                            | (67.0 | ) |   | (62.4 | ) |
| Proceeds from exercising stock warrants                                   | 26.6 |  |   | — |  |
| Distributions paid to noncontrolling interests of consolidated affiliates | (38.3 | ) |   | (49.5 | ) |
| Taxes paid on behalf of employees for shares withheld                     | (19.8 | ) |   | (9.9 | ) |
| Other, net                                                                | 6.5 |  |   | (7.2 | ) |
| Net cash used in financing activities                                     | (269.5 | ) |   | (328.3 | ) |
| Increase in cash and cash equivalents                                     | 27.1 |  |   | 14.8 |  |
| Cash and cash equivalents at beginning of period                          | 40.5 |  |   | 61.6 |  |
| Cash and cash equivalents at end of period                                | $ | 67.6 |  |   | $ | 76.4 |  |
|                                                                      |   |   |   |
| Supplemental schedule of noncash financing activity:                      |   |   |   |
| Conversion of convertible debt                                            | $ | 319.4 |  |   | $ | — |  |

|        |
|--------|
|        |  |  |
|   |   | 9 |

----

|                                                              |
|--------------------------------------------------------------|
|                                                              |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
|                                                         | Three Months Ended September 30, |   | Nine Months Ended September 30, |
|                                                         | 2017 |   | 2016 |   | 2017 |   | 2016 |
|                                                         | (In Millions, Except Per Share Data) |
| Adjusted EBITDA                                              | $ | 204.6 |  |   | $ | 198.4 |  |   | $ | 614.9 |  |   | $ | 594.8 |  |
| Interest expense and amortization of debt discounts and fees | (36.8 | ) |   | (42.5 | ) |   | (118.5 | ) |   | (130.5 | ) |
| Depreciation and amortization                                | (46.2 | ) |   | (43.5 | ) |   | (137.2 | ) |   | (128.8 | ) |
| Stock-based compensation expense                             | (9.2 | ) |   | (4.3 | ) |   | (37.9 | ) |   | (17.4 | ) |
| Noncash loss on disposal of assets                           | (3.0 | ) |   | (1.6 | ) |   | (3.3 | ) |   | (2.0 | ) |
|                                                         | 109.4 |  |   | 106.5 |  |   | 318.0 |  |   | 316.1 |  |
| Certain items non-indicative of ongoing operations:          |   |   |   |   |   |   |   |
| Loss on early extinguishment of debt                         | (0.3 | ) |   | (2.6 | ) |   | (10.7 | ) |   | (7.4 | ) |
| Professional fees—accounting, tax, and legal           | — |  |   | — |  |   | — |  |   | (1.9 | ) |
| Pre-tax income                                               | 109.1 |  |   | 103.9 |  |   | 307.3 |  |   | 306.8 |  |
| Income tax expense (1)                                       | (43.1 | ) |   | (42.1 | ) |   | (111.4 | ) |   | (124.2 | ) |
| Income from continuing operations (2)                        | $ | 66.0 |  |   | $ | 61.8 |  |   | $ | 195.9 |  |   | $ | 182.6 |  |
|                                                         |   |   |   |   |   |   |   |
| Basic shares (3)                                             | 97.8 |  |   | 89.1 |  |   | 92.3 |  |   | 89.3 |  |
| Diluted shares                                               | 99.0 |  |   | 99.4 |  |   | 99.1 |  |   | 99.5 |  |
|                                                         |   |   |   |   |   |   |   |
| Basic earnings per share (2)                                 | $ | 0.67 |  |   | $ | 0.69 |  |   | $ | 2.11 |  |   | $ | 2.03 |  |
| Diluted earnings per share (2)                               | $ | 0.67 |  |   | $ | 0.64 |  |   | $ | 2.08 |  |   | $ | 1.90 |  |

|           |                                                                                                                                                                                                                                                                                                       |
|-----------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| (1)  | Current income tax expense for the three months ended September 30, 2017 and 2016 was $36.0 million and $4.6 million, respectively. Current income tax expense for the nine months ended September 30, 2017 and 2016 was $60.1 million and $13.6 million, respectively. |

|           |                                                                |
|-----------|----------------------------------------------------------------|
| (2)  | Income from continuing operations attributable to HealthSouth. |

|           |                                                                                                                                                                                         |
|-----------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| (3)  | Increased basic share count in 2017 resulted from the Company's exercise of its early redemption option on its 2.0% Convertible Senior Subordinated Notes in the second quarter of 2017 |

|        |
|--------|
|        |  |  |
|   |   | 10 |

----

|                                                          |
|----------------------------------------------------------|
|                                                          |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
|                                                     | Q3 |   | 9 Months |
|                                                     | 2017 |   | 2016 |   | 2017 |   | 2016 |
|                                                     |   |   |   |   |   |   |   |
| Earnings per share, as reported                          | $ | 0.67 |  |   | $ | 0.64 |  |   | $ | 2.08 |  |   | $ | 1.90 |  |
| Adjustments, net of tax:                                 |   |   |   |   |   |   |   |
| Professional fees—accounting, tax, and legal       | — |  |   | — |  |   | — |  |   | 0.01 |  |
| Mark-to-market adjustments for stock appreciation rights | (0.01 | ) |   | (0.01 | ) |   | 0.08 |  |   | (0.01 | ) |
| Sale of hospital                                         | — |  |   | — |  |   | — |  |   | (0.01 | ) |
| Loss on early extinguishment of debt(1)                  | — |  |   | 0.02 |  |   | — |  |   | 0.04 |  |
| Income tax adjustments(2)                                | — |  |   | — |  |   | (0.10 | ) |   | — |  |
| Adjusted earnings per share(3)                           | $ | 0.66 |  |   | $ | 0.65 |  |   | $ | 2.07 |  |   | $ | 1.95 |  |

|           |                                                                                                                                                                                                                                                                                                                                                                                        |
|-----------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| (1)  | The interest and amortization and the loss on early extinguishment of debt related to the convertible senior subordinated notes must be added to income from continuing operations when calculating diluted earnings per share because the debt was assumed to have been converted at the beginning of the period, and the applicable shares were included in the diluted share count. |

|           |                                                                                                                       |
|-----------|-----------------------------------------------------------------------------------------------------------------------|
| (2)  | New guidance in ASU 2016-09, “Improvements to Employee Share-Based Payment Accounting,” requires entities |

|           |                                           |
|-----------|-------------------------------------------|
| (3)  | Adjusted EPS may not sum due to rounding. |

|        |
|--------|
|        |  |  |
|   |   | 11 |

----

|                                                                                         |
|-----------------------------------------------------------------------------------------|
|                                                                                         |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
|                                                                                    | For the Three Months Ended September 30, 2017 |
|                                                                                    |   |   | Adjustments |   |   |
|                                                                                    | As Reported |   | Mark-to-Market Adjustment for Stock Appreciation Rights |   | Income Tax Adjustments(1) |   | Loss on Early Extinguishment of Debt |   | As Adjusted |
|                                                                                    | (In Millions, Except Per Share Amounts) |
| Adjusted EBITDA(2)                                                                      | $ | 204.6 |  |   | $ | — |  |   | $ | — |  |   | $ | — |  |   | $ | 204.6 |  |
| Depreciation and amortization                                                           | (46.2 | ) |   | — |  |   | — |  |   | — |  |   | (46.2 | ) |
| Loss on early extinguishment of debt                                                    | (0.3 | ) |   | — |  |   | — |  |   | 0.3 |  |   | — |  |
| Interest expense and amortization of debt discounts and fees                            | (36.8 | ) |   | — |  |   | — |  |   | — |  |   | (36.8 | ) |
| Stock-based compensation                                                                | (9.2 | ) |   | (1.0 | ) |   | — |  |   | — |  |   | (10.2 | ) |
| Loss on disposal of assets                                                              | (3.0 | ) |   | — |  |   | — |  |   | — |  |   | (3.0 | ) |
| Income from continuing operations before income tax expense                             | 109.1 |  |   | (1.0 | ) |   | — |  |   | 0.3 |  |   | 108.4 |  |
| Provision for income tax expense                                                        | (43.1 | ) |   | 0.4 |  |   | (0.4 | ) |   | (0.1 | ) |   | (43.2 | ) |
| Income from continuing operations attributable to HealthSouth                           | $ | 66.0 |  |   | $ | (0.6 | ) |   | $ | (0.4 | ) |   | $ | 0.2 |  |   | $ | 65.2 |  |
| Add: Interest, amortization, and loss on extinguishment of convertible debt, net of tax | — |  |   |   |   |   |   |   |   | — |  |
| Numerator for diluted earnings per share                                                | $ | 66.0 |  |   |   |   |   |   |   |   | $ | 65.2 |  |
|                                                                                    |   |   |   |   |   |   |   |   |   |
| Diluted earnings per share from continuing operations, as reported(3)                   | $ | 0.67 |  |   | $ | (0.01 | ) |   | $ | — |  |   | $ | — |  |   | $ | 0.66 |  |
| Diluted shares used in calculation                                                      | 99.0 |  |   |   |   |   |   |   |   |   |

|           |                                                                                                                                                                                                                                                                                                                   |
|-----------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| (1)  | New guidance in ASU 2016-09, “Improvements to Employee Share-Based Payment Accounting,” requires entities to record all of the tax effects related to share-based payments at settlement (or expiration) through the income statement. Historically, HealthSouth recorded such tax effects to equity. |

|           |                                            |
|-----------|--------------------------------------------|
| (2)  | Reconciliation to GAAP provided on page 17 |

|           |                                                  |
|-----------|--------------------------------------------------|
| (3)  | Adjusted EPS may not sum across due to rounding. |

|        |
|--------|
|        |  |  |
|   |   | 12 |

----

|                                                               |
|---------------------------------------------------------------|
|                                                               |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
|                                                          | For the Three Months Ended September 30, 2016 |
|                                                          |   |   | Adjustments |   |   |
|                                                          | As Reported |   | Mark-to-Market Adjustment for Stock Appreciation Rights |   | Loss on Early Extinguishment of Debt |   | As Adjusted |
|                                                          | (In Millions, Except Per Share Amounts) |
| Adjusted EBITDA(1)                                            | $ | 198.4 |  |   | $ | — |  |   | $ | — |  |   | $ | 198.4 |  |
| Depreciation and amortization                                 | (43.5 | ) |   | — |  |   | — |  |   | (43.5 | ) |
| Loss on early extinguishment of debt                          | (2.6 | ) |   | — |  |   | 2.6 |  |   | — |  |
| Interest expense and amortization of debt discounts and fees  | (42.5 | ) |   | — |  |   | — |  |   | (42.5 | ) |
| Stock-based compensation                                      | (4.3 | ) |   | (1.8 | ) |   | — |  |   | (6.1 | ) |
| Loss on disposal of assets                                    | (1.6 | ) |   | — |  |   | — |  |   | (1.6 | ) |
| Income from continuing operations before income tax expense   | 103.9 |  |   | (1.8 | ) |   | 2.6 |  |   | 104.7 |  |
| Provision for income tax expense                              | (42.1 | ) |   | 0.7 |  |   | (1.0 | ) |   | (42.4 | ) |
| Income from continuing operations attributable to HealthSouth | $ | 61.8 |  |   | $ | (1.1 | ) |   | $ | 1.6 |  |   | $ | 62.3 |  |
| Add: Interest on convertible debt, net of tax                 | 2.4 |  |   |   |   |   |   | 2.4 |  |
| Numerator for diluted earnings per share                      | $ | 64.2 |  |   |   |   |   |   | $ | 64.7 |  |
|                                                          |   |   |   |   |   |   |   |
| Diluted earnings per share from continuing operations(2)      | $ | 0.64 |  |   | $ | (0.01 | ) |   | $ | 0.02 |  |   | $ | 0.65 |  |
| Diluted shares used in calculation                            | 99.4 |  |   |   |   |   |   |   |

|           |                                            |
|-----------|--------------------------------------------|
| (1)  | Reconciliation to GAAP provided on page 17 |

|           |                                                  |
|-----------|--------------------------------------------------|
| (2)  | Adjusted EPS may not sum across due to rounding. |

|        |
|--------|
|        |  |  |
|   |   | 13 |

----

|                                                                                         |
|-----------------------------------------------------------------------------------------|
|                                                                                         |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
|                                                                                    | For the Nine Months Ended September 30, 2017 |
|                                                                                    |   |   | Adjustments |   |   |
|                                                                                    | As Reported |   | Mark-to-Market Adjustment for Stock Appreciation Rights |   | Loss on Early Extinguishment of Debt |   | Income Tax Adjustments(1) |   | As Adjusted |
|                                                                                    | (In Millions, Except Per Share Amounts) |
| Adjusted EBITDA(2)                                                                      | $ | 614.9 |  |   | $ | — |  |   | $ | — |  |   | $ | — |  |   | $ | 614.9 |  |
| Depreciation and amortization                                                           | (137.2 | ) |   | — |  |   | — |  |   | — |  |   | (137.2 | ) |
| Loss on early extinguishment of debt                                                    | (10.7 | ) |   | — |  |   | 0.3 |  |   | — |  |   | (10.4 | ) |
| Interest expense and amortization of debt discounts and fees                            | (118.5 | ) |   | — |  |   | — |  |   | — |  |   | (118.5 | ) |
| Stock-based compensation                                                                | (37.9 | ) |   | 13.9 |  |   | — |  |   | — |  |   | (24.0 | ) |
| Loss on disposal of assets                                                              | (3.3 | ) |   | — |  |   | — |  |   | — |  |   | (3.3 | ) |
| Income from continuing operations before income tax expense                             | 307.3 |  |   | 13.9 |  |   | 0.3 |  |   | — |  |   | 321.5 |  |
| Provision for income tax expense                                                        | (111.4 | ) |   | (5.6 | ) |   | (0.1 | ) |   | (10.4 | ) |   | (127.5 | ) |
| Income from continuing operations attributable to HealthSouth                           | $ | 195.9 |  |   | $ | 8.3 |  |   | $ | 0.2 |  |   | $ | (10.4 | ) |   | $ | 194.0 |  |
| Add: Interest, amortization, and loss on extinguishment of convertible debt, net of tax | 10.8 |  |   |   |   |   |   |   |   | 10.8 |  |
| Numerator for diluted earnings per share                                                | $ | 206.7 |  |   |   |   |   |   |   |   | $ | 204.8 |  |
|                                                                                    |   |   |   |   |   |   |   |   |   |
| Diluted earnings per share from continuing operations, as reported(3)                   | $ | 2.08 |  |   | $ | 0.08 |  |   | $ | — |  |   | $ | (0.10 | ) |   | $ | 2.07 |  |
| Diluted shares used in calculation                                                      | 99.1 |  |   |   |   |   |   |   |   |   |

|           |                                                                                                                                                                                                                                                                                                                   |
|-----------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| (1)  | New guidance in ASU 2016-09, “Improvements to Employee Share-Based Payment Accounting,” requires entities to record all of the tax effects related to share-based payments at settlement (or expiration) through the income statement. Historically, HealthSouth recorded such tax effects to equity. |

|           |                                            |
|-----------|--------------------------------------------|
| (2)  | Reconciliation to GAAP provided on page 17 |

|           |                                                  |
|-----------|--------------------------------------------------|
| (3)  | Adjusted EPS may not sum across due to rounding. |

|        |
|--------|
|        |  |  |
|   |   | 14 |

----

|                                                               |
|---------------------------------------------------------------|
|                                                               |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
|                                                          | For the Nine Months Ended September 30, 2016 |
|                                                          |   |   | Adjustments |   |   |
|                                                          | As Reported |   | Professional Fees—Accounting, Tax, and Legal |   | Mark-to-Market Adjustment for Stock Appreciation Rights |   | Loss on Early Extinguishment of Debt |   | Sale of Hospital |   | As Adjusted |
|                                                          | (In Millions, Except Per Share Amounts) |
| Adjusted EBITDA(1)                                            | $ | 594.8 |  |   | $ | — |  |   | $ | — |  |   | $ | — |  |   | $ | — |  |   | $ | 594.8 |  |
| Depreciation and amortization                                 | (128.8 | ) |   | — |  |   | — |  |   | — |  |   | — |  |   | (128.8 | ) |
| Professional fees—accounting, tax, and legal            | (1.9 | ) |   | 1.9 |  |   | — |  |   | — |  |   | — |  |   | — |  |
| Loss on early extinguishment of debt                          | (7.4 | ) |   | — |  |   | — |  |   | 7.4 |  |   | — |  |   | — |  |
| Interest expense and amortization of debt discounts and fees  | (130.5 | ) |   | — |  |   | — |  |   | — |  |   | — |  |   | (130.5 | ) |
| Stock-based compensation                                      | (17.4 | ) |   | — |  |   | (1.4 | ) |   | — |  |   | — |  |   | (18.8 | ) |
| Loss on disposal of assets                                    | (2.0 | ) |   | — |  |   | — |  |   | — |  |   | (0.9 | ) |   | (2.9 | ) |
| Income from continuing operations before income tax expense   | 306.8 |  |   | 1.9 |  |   | (1.4 | ) |   | 7.4 |  |   | (0.9 | ) |   | 313.8 |  |
| Provision for income tax expense                              | (124.2 | ) |   | (0.8 | ) |   | 0.5 |  |   | (3.0 | ) |   | 0.4 |  |   | (127.1 | ) |
| Income from continuing operations attributable to HealthSouth | $ | 182.6 |  |   | $ | 1.1 |  |   | $ | (0.9 | ) |   | $ | 4.4 |  |   | $ | (0.5 | ) |   | $ | 186.7 |  |
| Add: Interest on convertible debt, net of tax                 | 7.2 |  |   |   |   |   |   |   |   |   |   | 7.2 |  |
| Numerator for diluted earnings per share                      | $ | 189.8 |  |   |   |   |   |   |   |   |   |   | $ | 193.9 |  |
|                                                          |   |   |   |   |   |   |   |   |   |   |   |
| Diluted earnings per share from continuing operations(2)      | $ | 1.90 |  |   | $ | 0.01 |  |   | $ | (0.01 | ) |   | $ | 0.04 |  |   | $ | (0.01 | ) |   | $ | 1.95 |  |
| Diluted shares used in calculation                            | 99.5 |  |   |   |   |   |   |   |   |   |   |   |

|           |                                            |
|-----------|--------------------------------------------|
| (1)  | Reconciliation to GAAP provided on page 17 |

|           |                                                  |
|-----------|--------------------------------------------------|
| (2)  | Adjusted EPS may not sum across due to rounding. |

|        |
|--------|
|        |  |  |
|   |   | 15 |

----

|                                                                            |
|----------------------------------------------------------------------------|
|                                                                            |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
|                                                                       | Three Months Ended September 30, |   | Nine Months Ended September 30, |
|                                                                       | 2017 |   | 2016 |   | 2017 |   | 2016 |
|                                                                       | (In Millions) |
| Net income                                                                 | $ | 85.1 |  |   | $ | 78.1 |  |   | $ | 248.9 |  |   | $ | 236.0 |  |
| Loss from discontinued operations, net of tax, attributable to HealthSouth | 0.1 |  |   | 0.1 |  |   | 0.2 |  |   | 0.3 |  |
| Provision for income tax expense                                           | 43.1 |  |   | 42.1 |  |   | 111.4 |  |   | 124.2 |  |
| Interest expense and amortization of debt discounts and fees               | 36.8 |  |   | 42.5 |  |   | 118.5 |  |   | 130.5 |  |
| Professional fees—accounting, tax, and legal                         | — |  |   | — |  |   | — |  |   | 1.9 |  |
| Loss on early extinguishment of debt                                       | 0.3 |  |   | 2.6 |  |   | 10.7 |  |   | 7.4 |  |
| Net noncash loss on disposal of assets                                     | 3.0 |  |   | 1.6 |  |   | 3.3 |  |   | 2.0 |  |
| Depreciation and amortization                                              | 46.2 |  |   | 43.5 |  |   | 137.2 |  |   | 128.8 |  |
| Stock-based compensation expense                                           | 9.2 |  |   | 4.3 |  |   | 37.9 |  |   | 17.4 |  |
| Net income attributable to noncontrolling interests                        | (19.2 | ) |   | (16.4 | ) |   | (53.2 | ) |   | (53.7 | ) |
| Adjusted EBITDA                                                            | $ | 204.6 |  |   | $ | 198.4 |  |   | $ | 614.9 |  |   | $ | 594.8 |  |

|                                                              |
|--------------------------------------------------------------|
|                                                              |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
|                                                         | Three Months Ended September 30, |   | Nine Months Ended September 30, |   | Year Ended December 31, 2016 |
|                                                         | 2017 |   | 2016 |   | 2017 |   | 2016 |   |
|                                                         | (In Millions) |
| Total segment Adjusted EBITDA                                | $ | 235.1 |  |   | $ | 224.4 |  |   | $ | 705.6 |  |   | $ | 674.0 |  |   | $ | 899.6 |  |
| General and administrative expenses                          | (39.7 | ) |   | (30.3 | ) |   | (128.6 | ) |   | (96.6 | ) |   | (133.4 | ) |
| Depreciation and amortization                                | (46.2 | ) |   | (43.5 | ) |   | (137.2 | ) |   | (128.8 | ) |   | (172.6 | ) |
| Loss on disposal of assets                                   | (3.0 | ) |   | (1.6 | ) |   | (3.3 | ) |   | (2.0 | ) |   | (0.7 | ) |
| Professional fees—accounting, tax, and legal           | — |  |   | — |  |   | — |  |   | (1.9 | ) |   | (1.9 | ) |
| Loss on early extinguishment of debt                         | (0.3 | ) |   | (2.6 | ) |   | (10.7 | ) |   | (7.4 | ) |   | (7.4 | ) |
| Interest expense and amortization of debt discounts and fees | (36.8 | ) |   | (42.5 | ) |   | (118.5 | ) |   | (130.5 | ) |   | (172.1 | ) |
| Net income attributable to noncontrolling interests          | 19.2 |  |   | 16.4 |  |   | 53.2 |  |   | 53.7 |  |   | 70.5 |  |
| Income from continuing operations before income tax expense  | $ | 128.3 |  |   | $ | 120.3 |  |   | $ | 360.5 |  |   | $ | 360.5 |  |   | $ | 482.0 |  |

|        |
|--------|
|        |  |  |
|   |   | 16 |

----

|                                                                              |
|------------------------------------------------------------------------------|
|                                                                              |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
|                                                                         | Three Months Ended September 30, |   | Nine Months Ended September 30, |   | Year Ended December 31, |
|                                                                         |   |   |
|                                                                         | 2017 |   | 2016 |   | 2017 |   | 2016 |   | 2016 |   | 2015 |
|                                                                         | (In Millions) |
| Net cash provided by operating activities                                    | $ | 173.8 |  |   | $ | 177.6 |  |   | $ | 505.8 |  |   | $ | 499.4 |  |   | $ | 634.4 |  |   | $ | 502.0 |  |
| Provision for doubtful accounts                                              | (12.6 | ) |   | (14.8 | ) |   | (42.7 | ) |   | (46.7 | ) |   | (61.2 | ) |   | (47.2 | ) |
| Professional fees—accounting, tax, and legal                           | — |  |   | — |  |   | — |  |   | 1.9 |  |   | 1.9 |  |   | 3.0 |  |
| Interest expense and amortization of debt discounts and fees                 | 36.8 |  |   | 42.5 |  |   | 118.5 |  |   | 130.5 |  |   | 172.1 |  |   | 142.9 |  |
| Equity in net income of nonconsolidated affiliates                           | 2.1 |  |   | 2.5 |  |   | 6.2 |  |   | 7.3 |  |   | 9.8 |  |   | 8.7 |  |
| Net income attributable to noncontrolling interests in continuing operations | (19.2 | ) |   | (16.4 | ) |   | (53.2 | ) |   | (53.7 | ) |   | (70.5 | ) |   | (69.7 | ) |
| Amortization of debt-related items                                           | (1.0 | ) |   | (3.5 | ) |   | (7.7 | ) |   | (10.3 | ) |   | (13.8 | ) |   | (14.3 | ) |
| Distributions from nonconsolidated affiliates                                | (2.2 | ) |   | (2.9 | ) |   | (6.6 | ) |   | (5.9 | ) |   | (8.5 | ) |   | (7.7 | ) |
| Current portion of income tax expense                                        | 36.0 |  |   | 4.6 |  |   | 60.1 |  |   | 13.6 |  |   | 31.0 |  |   | 14.8 |  |
| Change in assets and liabilities                                             | (9.8 | ) |   | 6.4 |  |   | 32.6 |  |   | 51.7 |  |   | 91.3 |  |   | 129.9 |  |
| Net premium paid on bond transactions                                        | — |  |   | 1.9 |  |   | — |  |   | 5.8 |  |   | 5.8 |  |   | 3.9 |  |
| Net cash used in operating activities of discontinued operations             | 0.1 |  |   | 0.1 |  |   | 0.7 |  |   | 0.6 |  |   | 0.7 |  |   | 0.7 |  |
| Transaction costs                                                            | — |  |   | — |  |   | — |  |   | — |  |   | — |  |   | 12.3 |  |
| Other                                                                        | 0.6 |  |   | 0.4 |  |   | 1.2 |  |   | 0.6 |  |   | 0.6 |  |   | 3.2 |  |
| Consolidated Adjusted EBITDA                                                 | $ | 204.6 |  |   | $ | 198.4 |  |   | $ | 614.9 |  |   | $ | 594.8 |  |   | $ | 793.6 |  |   | $ | 682.5 |  |

|        |
|--------|
|        |  |  |
|   |   | 17 |

----

|                                                                           |
|---------------------------------------------------------------------------|
|                                                                           |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
|                                                                      | Three Months Ended September 30, |   | Nine Months Ended September 30, |
|                                                                      |   |
|                                                                      | 2017 |   | 2016 |   | 2017 |   | 2016 |
|                                                                      | (In Millions) |
| Net cash provided by operating activities                                 | $ | 173.8 |  |   | $ | 177.6 |  |   | $ | 505.8 |  |   | $ | 499.4 |  |
| Impact of discontinued operations                                         | 0.1 |  |   | 0.1 |  |   | 0.7 |  |   | 0.6 |  |
| Net cash provided by operating activities of continuing operations        | 173.9 |  |   | 177.7 |  |   | 506.5 |  |   | 500.0 |  |
| Capital expenditures for maintenance                                      | (37.6 | ) |   | (23.9 | ) |   | (92.1 | ) |   | (64.5 | ) |
| Distributions paid to noncontrolling interests of consolidated affiliates | (14.2 | ) |   | (15.9 | ) |   | (38.3 | ) |   | (49.5 | ) |
| Items non-indicative of ongoing operations:                               |   |   |   |   |   |   |   |
| Cash paid for professional fees—accounting, tax, and legal          | — |  |   | — |  |   | — |  |   | 1.9 |  |
| Transaction costs and related assumed liabilities                         | — |  |   | — |  |   | — |  |   | 0.8 |  |
| Net premium on bond issuance/repayment                                    | — |  |   | 1.9 |  |   | — |  |   | 5.8 |  |
| Adjusted free cash flow                                                   | $ | 122.1 |  |   | $ | 139.8 |  |   | $ | 376.1 |  |   | $ | 394.5 |  |

|        |
|--------|
|        |  |  |
|   |   | 18 |

----

|        |
|--------|
|        |  |  |
|   |   | 19 |